Covalon Technologies Ltd. (OTCMKTS:CVALF) Stock Short Interest Report for October

Covalon Technologies Ltd. (OTCMKTS:CVALF) was the recipient of a large decrease in short interest in the month of October. As of October 15th, there was short interest totaling 24,176 shares, a decrease of 57.2% from the September 30th total of 56,447 shares. Currently, 0.1% of the company’s stock are short sold. Based on an average daily volume of 23,579 shares, the short-interest ratio is presently 1.0 days.

Covalon Technologies Trading Down 0.8%

OTCMKTS:CVALF traded down $0.02 on Friday, hitting $3.16. The company’s stock had a trading volume of 8,500 shares, compared to its average volume of 13,182. Covalon Technologies has a one year low of $1.16 and a one year high of $3.65. The firm has a market capitalization of $87.17 million, a P/E ratio of 28.69 and a beta of 0.78. The stock has a fifty day moving average of $2.61 and a two-hundred day moving average of $1.71.

Covalon Technologies (OTCMKTS:CVALF) last announced its quarterly earnings data on Thursday, August 27th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.06. The firm had revenue of $7.07 million during the quarter, compared to analysts’ expectations of $6.65 million. Covalon Technologies had a return on equity of 15.11% and a net margin of 12.77%.

About Covalon Technologies

Covalon Technologies Ltd. is a Canadian medical technology company that develops, manufactures and commercializes healthcare products designed to support wound care, infection prevention and surgical procedures. Its technologies are intended for use by hospitals, healthcare professionals and patients in managing wounds and protecting skin.

The company’s product portfolio includes advanced wound dressings, antimicrobial and protective barriers, surgical incision dressings, and other solutions for skin and tissue management.